Navigation Links
PhRMA Statement Supporting Fair Incentives for Biologics Innovation
Date:10/19/2009

have the potential to circumvent patents -- while qualifying for an abbreviated application.

"Economists and the venture capitalists whose private investments shore up this vital, yet vulnerable sector agree: 12 years of data protection, at a bare minimum, are needed to help recoup the significant development costs for biologic innovators. That, however, does not constitute market exclusivity. Companies could still seek approval of competing biologics using their own data, but for those 12 years no biosimilar competitor could rely on innovators' hard-earned data, collected during development that may span a decade, or more, to seek approval.

"For many biologics on the market right now, the 12-year data protection clock began ticking long ago, when federal regulators approved the therapy. In addition to the brand-to-brand competition that already occurs for biologics, those biologic medicines could face biosimilar competitors relatively soon; multiple biosimilars are already on the market in Europe.

"Biosimilar versions of current biologics may well be approved before 12 years have elapsed after the law's enactment, but 12 years of data protection is important to provide incentives for manufacturers to create the next wave of innovative biologics.

"Giving short shrift to incentives for innovation would grind to a halt uniquely American innovation, moving critically important R&D -- and tens of thousands of U.S. jobs -- overseas. Right now, 80 percent of the world's biotech research occurs in the U.S.

"A diverse group of supporters agree with the need for adequate data protection, from patients eagerly awaiting new therapies to elected officials who understand how tenuous U.S. leadership in biologics research could become if incentives for innovation are weakened:

  • 'Many of these biologics will be developed from early-stage discoveries arising from basic research conducted by universities. ..
    '/>"/>

SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. PhRMA Statement on Senate Finance Committee Vote
2. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
3. SCAI Statement on the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation With Diabetes Trial) Presented at the American Diabetes Association (ADA) Annual Scientific Sessions and Published in The New England Journal of Medicine
4. EAU Position Statement on Screening for Prostate Cancer
5. Joint Statement from the American Diabetes Association and American Association of Clinical Endocrinologists on the NICE-SUGAR Study on Intensive Versus Conventional Glucose Control in Critically Ill Patients
6. A Joint Statement From Americas Prostate Cancer Advocacy, Education, and Support Organizations
7. Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients
8. American Heart Association Scientific Statement: Heart Patients Should Be Screened, Treated for Depression
9. Deer Farm Industry in Michigan Issues Statement on the Negative CWD Test Results at Kent County Deer Farm
10. VA Statement on Smoking Cessation Research Program
11. Statement From the Lupus Foundation of America Regarding the Release of Top-Line Results From a Study of Rituxan for the Treatment of Lupus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... Aug. 04, 2015 ... the addition of the "MRI Systems Market ... Operational Efficiency, with Growth Driven by Developing Economies" ... Systems Market to 2020 - Focus on Patient ... Developing Economies" discusses the market, competitive landscape, and ...
(Date:8/4/2015)... Pharmaceuticals, Inc. (Nasdaq: ISIS ) today reported net ... three and six months ended June 30, 2015, respectively, ... $43.4 million for the same periods in 2014. Isis, ... more than $90 million of revenue Isis earned in ... Bayer to license  ISIS-FXI Rx .  Isis increased its ...
(Date:8/4/2015)... 4, 2015 Research and Markets ( ... Jain PharmaBiotech,s new report "Transdermal Drug ... to their offering. This ... an approach used to deliver drugs through ... alternative to oral,intravascular, subcutaneous and transmucosal routes. ...
Breaking Medicine Technology:Global MRI Systems Market Outlook to 2020 - Focus on Patient Comfort and Operational Efficiency, with Growth Driven by Developing Economies 2Isis Reports Financial Results And Highlights For Second Quarter 2015 2Isis Reports Financial Results And Highlights For Second Quarter 2015 3Isis Reports Financial Results And Highlights For Second Quarter 2015 4Isis Reports Financial Results And Highlights For Second Quarter 2015 5Isis Reports Financial Results And Highlights For Second Quarter 2015 6Isis Reports Financial Results And Highlights For Second Quarter 2015 7Isis Reports Financial Results And Highlights For Second Quarter 2015 8Isis Reports Financial Results And Highlights For Second Quarter 2015 9Isis Reports Financial Results And Highlights For Second Quarter 2015 10Isis Reports Financial Results And Highlights For Second Quarter 2015 11Isis Reports Financial Results And Highlights For Second Quarter 2015 12Isis Reports Financial Results And Highlights For Second Quarter 2015 13Isis Reports Financial Results And Highlights For Second Quarter 2015 14Isis Reports Financial Results And Highlights For Second Quarter 2015 15Isis Reports Financial Results And Highlights For Second Quarter 2015 16Transdermal Drug Delivery Report 2015-2024 - Technologies, Markets, and Companies Analysis 2
(Date:8/4/2015)... , ... August 04, 2015 , ... An article ... financial incentives to be a viable method for encouraging people to lose weight. Specifically ... the future of their weight loss success, adding a financial incentive to the overall ...
(Date:8/4/2015)... ... 04, 2015 , ... Angelina Jolie is in it at age 39. “It” ... Dr. Angela DeRosa, DO, MBA, CPE aka “Dr. Hot Flash,” arguably the ... out of menopause. , Myth #1: Menopause only affects old ladies. – Menopause ...
(Date:8/4/2015)... ... August 04, 2015 , ... Worldwide Power Products acquires new ... its reach in Texas. Effective July 1st of this year, Worldwide Power Products ... With the North Texas acquisition, Worldwide Power Products (“WPP”) now services 1000 ...
(Date:8/4/2015)... ... 04, 2015 , ... Recent studies in the ... in binge drinking among certain populations and specific locations. Researchers, who ... examine trends and evidence to help facilitate health care treatment to meet current ...
(Date:8/4/2015)... ... 2015 , ... Members receiving care from a doctor who participates in a ... is nine percent lower -- than those members at traditional doctor practices, according to ... , “The promise of patient-centered, or value-based, care to deliver better quality care ...
Breaking Medicine News(10 mins):Health News:Article on Incentivizing Weight Loss Mirrors Similar Motivations Surrounding Weight Loss Surgery, Says Dr. Feiz & Associates 2Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 2Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 3Health News:North Texas Acquisition Press Release 2Health News:DARA Responds To International Trends in Binge Drinking 2Health News:DARA Responds To International Trends in Binge Drinking 3Health News:Horizon BCBSNJ: 2014 Results Show Patient-Centered Care Continues to Deliver on Promise of Better Quality Care at a Lower Cost 2Health News:Horizon BCBSNJ: 2014 Results Show Patient-Centered Care Continues to Deliver on Promise of Better Quality Care at a Lower Cost 3
... everyday life, emotional support, and cultural and recreational activities ... were the results of a dissertation from the Sahlgrenska ... amongst teenagers have increased markedly in recent years, especially ... as many as seven out of ten teenage girls ...
... pointers for better food choices for kids , , ... children dive into the pool, head to the park, and ... they may also leave nutrition behind; nutrition essential to fuel ... nutrition expert Chere Bork, a registered dietitian with more than ...
... the 400,000-strong seniors group RetireSafe saluted the Pharmaceutical ... commitment to support legislation to cut prescription drug ... into the Medicare Part D Prescription Drug Program ... "a huge gift to older Americans caught in ...
... suggests a direct link between smoking and brain damage will ... of Neurochemistry . Researchers, led by Debapriya Ghosh and Dr ... have found that a compound in tobacco provokes white blood ... leading to severe neurological damage. The research centers ...
... 23 Anglo Coal South Africa,a wholly owned subsidiary ... Coalition (GBC) on HIV/AIDS, Tuberculosis and Malaria for its,pioneering ... South,Africa. Anglo American is South Africa,s leading private sector ... The Business Excellence Award for ...
... 23 Helix BioPharma Corp. (TSX, FSE: HBP; OTCQX: HXBPF) ... on the OTCQX International Market under the ticker symbol HXBPF. ... about the OTCQX International Market at www.otcqx.com ... enhanced local access to the largest capital market in the ...
Cached Medicine News:Health News:How adolescent girls manage stress 2Health News:Summer is Here! Top Five Tips for Making Your Child's Summer Eating Habits Healthier 2Health News:New research discovers link between smoking and brain damage 2Health News:Anglo American's Coal Division in South Africa Wins Global Business Coalition Award for top International Workplace HIV and AIDS Programme 2Health News:Anglo American's Coal Division in South Africa Wins Global Business Coalition Award for top International Workplace HIV and AIDS Programme 3Health News:Helix Biopharma Corp. Begins Trading on the OTCQX International Market Listing as HXBPF 2Health News:Helix Biopharma Corp. Begins Trading on the OTCQX International Market Listing as HXBPF 3Health News:Helix Biopharma Corp. Begins Trading on the OTCQX International Market Listing as HXBPF 4
... device for the qualitative detection of drug or ... device can detect up to nine of the ... minutes and requires only a few drops of ... maximize convenience and ease of use. TOX/See features ...
... TOX/See™ is a 1-step, hand-held, point-of-care device ... metabolites in human urine. The TOX/See device ... commonly abused drugs in 3 to 8 minutes ... Each TOX/See cassette is individually packaged to maximize ...
... a 1-step, hand-held, point-of-care device for the qualitative ... urine. The TOX/See device can detect up ... in 3 to 8 minutes and requires only ... is individually packaged to maximize convenience and ease ...
... TOX/See™ is a 1-step, hand-held, point-of-care device for ... in human urine. The TOX/See device can ... abused drugs in 3 to 8 minutes and ... TOX/See cassette is individually packaged to maximize convenience ...
Medicine Products: